Hikma has strong start to 2024, with continued momentum across all businesses. Full year guidance reiterated
2024-04-25
Amman, Jordan Hikma Pharmaceuticals PLC (Hikma, Group), the multinational pharmaceutical group, today provides an update on current trading ahead of its Annual General Meeting. Riad Mishlawi, Hikma’s CEO, said: “Hikma has had a strong start to 2024, with continued growth and momentum across the Group. Our three businesses are performingContinue Reading